Tradestie Institutional Equity Comparison Engine
SGMT vs CAMP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGMT Overall Edge
SGMT Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sagimet Biosciences Inc. Series A Common Stock (SGMT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGMT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, SGMT sits in BREAKOUT (5th %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SGMT N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner
SGMT
Op Margin 0.0% vs -991.8% ยท YoY +0.0% vs +138.9%
Momentum & Technical Winner
SGMT
1Y +26.1% vs -2.4% ยท 52W Pos 76% vs 23%
Options & Structure Winner
SGMT
BREAKOUT (5th %ile IV) vs UNCLASSIFIED (N/A IV)
SGMT
NASDAQ
Sagimet Biosciences Inc. Series A Common Stock
Pharmaceutical Preparations
$9.78
-3.5% 1D
Market Cap
$735.2M
1M Return
+10.33%
1Y Return
+26.13%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 36.0
Fund 54.0
Flow 69.0
Mom 60.0
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap
$238.5M
1M Return
+27.39%
1Y Return
-2.44%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGMT +26.13%
CAMP -2.44%
Spread: +28.57 pp (SGMT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SGMT Revenue | CAMP Revenue | SGMT Op. Margin | CAMP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2023 | $0M | $0M | -1537.0% | -14822.6% | SGMT |
| FY2024 | N/A | $0M | N/A | -8142.3% | CAMP |
| FY2025 | N/A | $0M | N/A | -1502.4% | CAMP |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGMT | CAMP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $735.2M | $238.5M | Larger Scale | SGMT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +138.9% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | 0.0% | -991.8% | Higher Margin | SGMT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -29.5% | -146.1% | Higher ROE | SGMT |
| 52-Week Range Position Momentum | 76% ($4โ$11) | 23% ($3โ$8) | Stronger Trend | SGMT |
| Beta / 30D Volatility Risk Regime | 2.08ฮฒ ยท 84% Vol | 1.35ฮฒ ยท 94% Vol | Lower Realized Risk | SGMT |
| Unified Institutional Score Composite Signal | 52.6 / 100 (HOLD) | 43.9 / 100 (HOLD) | Higher Composite | SGMT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGMT vs CAMP Buy Guide
SGMT
BREAKOUT
141d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGMT nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.